Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$132.62
+0.2%
$132.07
$99.71
$141.23
$230.91B0.736.10 million shs3.32 million shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$509.77
+0.1%
$527.71
$413.82
$616.00
$183.06B1.671.67 million shs1.10 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$149.47
-0.8%
$154.11
$140.68
$169.99
$359.86B0.427.95 million shs4.74 million shs
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$273.96
+0.0%
$255.59
$190.90
$280.25
$762.18B1.089.51 million shs6.59 million shs
Raymond James Financial, Inc. stock logo
RJF
Raymond James Financial
$148.54
+0.1%
$143.82
$104.24
$174.32
$30.02B1.031.32 million shs562,157 shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%-2.92%-2.09%+4.89%+27.27%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.00%-0.68%-8.56%+3.45%+17.12%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.00%-3.73%-1.83%-7.73%+3.51%
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
0.00%+2.15%+3.12%+13.39%+39.00%
Raymond James Financial, Inc. stock logo
RJF
Raymond James Financial
0.00%-0.36%-2.84%+4.86%+24.60%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.9303 of 5 stars
2.45.04.24.53.02.52.5
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
4.7794 of 5 stars
3.45.00.04.03.02.51.9
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.9341 of 5 stars
3.35.04.23.93.01.71.9
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
4.7893 of 5 stars
2.25.04.22.02.23.32.5
Raymond James Financial, Inc. stock logo
RJF
Raymond James Financial
4.4368 of 5 stars
2.22.02.53.52.82.52.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.76
Moderate Buy$142.617.28% Upside
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
2.70
Moderate Buy$588.9514.98% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.55
Moderate Buy$170.8814.17% Upside
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
2.48
Hold$271.70-1.31% Downside
Raymond James Financial, Inc. stock logo
RJF
Raymond James Financial
2.31
Hold$153.823.16% Upside

Current Analyst Ratings Breakdown

Latest RJF, JPM, ISRG, JNJ, and ABT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/18/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$300.00 ➝ $325.00
6/16/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
6/16/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageMarket Perform$143.00
6/10/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$300.00 ➝ $320.00
6/9/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeHold ➝ Sell$515.00 ➝ $440.00
6/5/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy
6/5/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$181.00
6/4/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
6/2/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
6/2/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
6/2/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingEqual Weight ➝ Equal Weight
(Data available from 6/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$42.34B5.46$6.61 per share20.11$27.62 per share4.81
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$8.35B21.98$8.03 per share63.78$46.41 per share11.04
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$88.82B4.05$13.03 per share11.49$29.69 per share5.04
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$278.91B2.74$22.13 per share12.44$115.33 per share2.39
Raymond James Financial, Inc. stock logo
RJF
Raymond James Financial
$14.92B2.02$11.13 per share13.40$56.27 per share2.65
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$13.40B$7.7117.2423.202.5131.89%19.01%10.82%7/17/2025 (Estimated)
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.32B$6.8275.1067.135.4028.41%14.43%12.81%7/17/2025 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$14.07B$8.9916.6513.522.2824.42%33.46%13.30%7/16/2025 (Estimated)
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$58.47B$20.3713.5214.182.7621.21%16.88%1.31%7/14/2025 (Estimated)
Raymond James Financial, Inc. stock logo
RJF
Raymond James Financial
$2.07B$10.3914.3412.381.7813.99%19.31%2.74%7/23/2025 (Estimated)

Latest RJF, JPM, ISRG, JNJ, and ABT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/17/2025Q2 2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.25N/AN/AN/A$11.01 billionN/A
7/17/2025Q2 2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$1.92N/AN/AN/A$2.35 billionN/A
7/16/2025Q2 2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.65N/AN/AN/A$22.85 billionN/A
7/14/2025Q2 2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$4.45N/AN/AN/A$43.76 billionN/A
4/23/2025Q2 2025
Raymond James Financial, Inc. stock logo
RJF
Raymond James Financial
$2.44$2.42-$0.02$2.36$3.46 billion$3.40 billion
4/22/2025Q1 2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$1.71$1.81+$0.10$1.92$2.19 billion$2.25 billion
4/16/2025Q1 2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.07$1.09+$0.02$0.76$10.38 billion$10.36 billion
4/15/2025Q1 2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.59$2.77+$0.18$4.54$21.65 billion$21.89 billion
4/11/2025Q1 2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$4.63$5.07+$0.44$5.07$43.62 billion$45.30 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.361.78%N/A30.61%54 Years
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/AN/AN/AN/AN/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$5.203.47%N/A57.84%64 Years
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
$5.602.03%N/A27.49%15 Years
Raymond James Financial, Inc. stock logo
RJF
Raymond James Financial
$2.001.34%N/A19.25%3 Years

Latest RJF, JPM, ISRG, JNJ, and ABT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/13/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.591.73%7/15/20257/15/20258/15/2025
5/19/2025
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
quarterly$1.402.12%7/3/20257/3/20257/31/2025
5/21/2025
Raymond James Financial, Inc. stock logo
RJF
Raymond James Financial
quarterly$0.501.35%7/1/20257/1/20257/15/2025
4/15/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.303.37%5/27/20255/27/20256/10/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.26
1.78
1.27
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/A
4.98
3.97
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.49
1.26
1.03
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
1.23
0.89
0.89
Raymond James Financial, Inc. stock logo
RJF
Raymond James Financial
0.32
1.04
1.02
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
114,0001.74 billion1.73 billionOptionable
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
15,638358.42 million355.91 millionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
138,1002.41 billion2.40 billionOptionable
JPMorgan Chase & Co. stock logo
JPM
JPMorgan Chase & Co.
317,2332.78 billion2.77 billionOptionable
Raymond James Financial, Inc. stock logo
RJF
Raymond James Financial
19,000201.76 million200.67 millionOptionable

Recent News About These Companies

RJF Recruits New Orleans UBS Team WIth $340M AUM
Insider Purchase: Director at $MMS Buys 1,435 Shares
Raymond James Initiates Coverage of Vistra (VST)
Raymond James Initiates Coverage of Entergy (ETR)
Insider Sale: Director at $EPR Sells 3,796 Shares

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$132.62 +0.21 (+0.16%)
As of 02:57 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Intuitive Surgical stock logo

Intuitive Surgical NASDAQ:ISRG

$509.77 +0.28 (+0.05%)
As of 02:57 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$149.47 -1.26 (-0.83%)
As of 02:57 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

JPMorgan Chase & Co. stock logo

JPMorgan Chase & Co. NYSE:JPM

$273.96 +0.00 (+0.00%)
As of 02:57 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

Raymond James Financial stock logo

Raymond James Financial NYSE:RJF

$148.54 +0.20 (+0.13%)
As of 02:57 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Raymond James Financial, Inc., a financial holding company, through its subsidiaries, engages in the underwriting, distribution, trading, and brokerage of equity and debt securities, and the sale of mutual funds and other investment products in the United States, Canada, Europe, and internationally. The company operates through Private Client Group, Capital Markets, Asset Management, RJ Bank, and Other segments. The Private Client Group segment provides securities brokerage services, including the sale of equities, mutual funds, fixed income products, and insurance products to their individual clients; and borrowing and lending of securities to and from other broker-dealers, financial institutions, and other counterparties. The Capital Markets segment offers securities brokerage, trading, and research services to institutions with a focus on sale of the United States and Canadian equities and fixed income products; and manages and participates in underwritings, merger and acquisition services, and public finance activities. The Asset Management segment engages in the operations of Eagle, the Eagle Family of Funds, Cougar, the asset management operations of Raymond James & Associates, trust services of Raymond James Trust, and other fee-based asset management programs. The RJ Bank segment provides corporate loans, SBL, tax-exempt loans, and residential loans. The Other segment engages in private equity activities, including various direct and third party private equity investments; and private equity funds. Raymond James Financial, Inc. was founded in 1962 and is based in St. Petersburg, Florida.